Pharmacological treatment options for mast cell activation disease

Mast cell activation disease (MCAD) is a term referring to a heterogeneous group of disorders characterized by aberrant release of variable subsets of mast cell (MC) mediators together with accumulation of either morphologically altered and immunohistochemically identifiable mutated MCs due to MC pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Naunyn Schmiedebergs Arch Pharmacol
Main Authors: Molderings, Gerhard J., Haenisch, Britta, Brettner, Stefan, Homann, Jürgen, Menzen, Markus, Dumoulin, Franz Ludwig, Panse, Jens, Butterfield, Joseph, Afrin, Lawrence B.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2016
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4903110/
https://ncbi.nlm.nih.gov/pubmed/27132234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00210-016-1247-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados